NCT06565234 VR in Neurosurgery: Planning, Training & Communication
| NCT ID | NCT06565234 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Brain Pathology |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-06-10 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-06-10 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective study analyzes the broad impact of virtual reality (VR) assistance on aneurysm surgeries through two primary focuses: first, it evaluates VR-assisted clip planning by examining its clinical outcomes in the operative management of aneurysms, and second, it investigates the role of VR-assisted patient-informed consent, including its effects on patient comprehension, the patient-doctor relationship, and anxiety.
Eligibility Criteria
Inclusion Criteria: * The patient is able to give written consent (or written consent by legal representative) * Preoperative imaging demonstrating intracranial pathology * Cognitively able to provide answers for the questionnaires Exclusion Criteria: * No informed consent * Adult patients without the power of judgement
Contact & Investigator
Attill Saemann, MD
PRINCIPAL INVESTIGATOR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT06565234 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Pathology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06565234 currently recruiting?
Yes, NCT06565234 is actively recruiting participants. Contact the research team at neurochirurgie@usb.ch for enrollment information.
Where is the NCT06565234 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT06565234 clinical trial?
NCT06565234 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Attill Saemann, MD at University Hospital, Basel, Switzerland. The trial plans to enroll 60 participants.